Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
Alexandra C MurphyAnoop N KoshyWilliam CameronMark HorriganLeighton KearneyBelinda YeoOmar FarouqueMatias B YudiPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In patients with severe AS undergoing TAVR, a history of cancer was not associated with adverse short or long-term survival. Based on these findings, TAVR should be considered in all patients with severe symptomatic AS, irrespective of their history of malignancy.